NantHealth (NH) Competitors $0.01 0.00 (0.00%) As of 07/14/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsSustainabilityTrendsBuy This Stock NH vs. CAUD, ASAP, MULN, WEJOF, ADVWW, MMA, AUUDW, BAOS, BIAFW, and CFFEWShould you be buying NantHealth stock or one of its competitors? The main competitors of NantHealth include Collective Audience (CAUD), Waitr (ASAP), Mullen Automotive (MULN), Wejo Group (WEJOF), Advantage Solutions (ADVWW), Alta Global Group (MMA), Auddia (AUUDW), Baosheng Media Group (BAOS), bioAffinity Technologies (BIAFW), and CF Acquisition Corp. VIII (CFFEW). These companies are all part of the "business services" industry. NantHealth vs. Its Competitors Collective Audience Waitr Mullen Automotive Wejo Group Advantage Solutions Alta Global Group Auddia Baosheng Media Group bioAffinity Technologies CF Acquisition Corp. VIII NantHealth (NASDAQ:NH) and Collective Audience (NASDAQ:CAUD) are both small-cap business services companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, analyst recommendations, media sentiment, dividends, risk, institutional ownership and earnings. Which has more volatility and risk, NH or CAUD? NantHealth has a beta of 1.82, meaning that its share price is 82% more volatile than the S&P 500. Comparatively, Collective Audience has a beta of 2.93, meaning that its share price is 193% more volatile than the S&P 500. Does the media favor NH or CAUD? In the previous week, NantHealth's average media sentiment score of 0.00 equaled Collective Audience'saverage media sentiment score. Company Overall Sentiment NantHealth Neutral Collective Audience Neutral Which has better earnings & valuation, NH or CAUD? Collective Audience has lower revenue, but higher earnings than NantHealth. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNantHealth$67.68M0.00-$67.78M-$7.650.00Collective Audience$12.14M0.07-$4.57MN/AN/A Is NH or CAUD more profitable? Collective Audience has a net margin of 0.00% compared to NantHealth's net margin of -94.67%. Company Net Margins Return on Equity Return on Assets NantHealth-94.67% N/A -39.82% Collective Audience N/A N/A N/A Do institutionals & insiders have more ownership in NH or CAUD? 4.5% of NantHealth shares are owned by institutional investors. Comparatively, 60.8% of Collective Audience shares are owned by institutional investors. 61.3% of NantHealth shares are owned by company insiders. Comparatively, 58.0% of Collective Audience shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. SummaryCollective Audience beats NantHealth on 6 of the 8 factors compared between the two stocks. Get NantHealth News Delivered to You Automatically Sign up to receive the latest news and ratings for NH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NH vs. The Competition Export to ExcelMetricNantHealthData processing & preparation IndustryMedical SectorNASDAQ ExchangeMarket Cap$85K$1.28B$5.56B$9.30BDividend YieldN/A6.01%4.23%4.03%P/E Ratio0.005.5428.6119.64Price / Sales0.0022.21437.49188.30Price / CashN/A33.2136.0257.93Price / Book0.000.958.185.63Net Income-$67.78M-$41.80M$3.23B$257.73M7 Day PerformanceN/A-1.31%-0.25%0.07%1 Month PerformanceN/A-1.45%5.40%8.32%1 Year PerformanceN/A-27.48%26.35%13.78% NantHealth Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NHNantHealthN/A$0.01flatN/AN/A$85K$67.68M0.00340CAUDCollective AudienceN/A$0.01-47.7%N/A-93.7%$276K$12.14M0.0023Gap UpASAPWaitrN/AN/AN/AN/A$237K$130.00M0.00840MULNMullen AutomotiveN/A$0.24+7.4%N/A-100.0%$99K$8.93M0.00120Trending NewsGap DownHigh Trading VolumeWEJOFWejo GroupN/A$0.00flatN/A+0.0%$11K$8.40M0.00300ADVWWAdvantage SolutionsN/A$0.01+0.8%N/A-77.8%$0.00$3.53B0.0075,000Positive NewsGap DownMMAAlta Global GroupN/A$1.23-1.6%N/A-59.1%$0.00$562.31K0.00N/AGap UpAUUDWAuddiaN/A$0.03+10.3%N/AN/A$0.00N/A0.0020BAOSBaosheng Media Group1.5688 of 5 stars$2.61-5.1%N/A+19.9%$0.00$620K0.00130BIAFWbioAffinity TechnologiesN/A$0.13-10.2%N/A-74.9%$0.00$8.81M0.0010News CoverageGap DownCFFEWCF Acquisition Corp. VIIIN/A$0.05flatN/A-67.5%$0.00N/A0.003 Related Companies and Tools Related Companies CAUD Alternatives ASAP Alternatives MULN Alternatives WEJOF Alternatives ADVWW Alternatives MMA Alternatives AUUDW Alternatives BAOS Alternatives BIAFW Alternatives CFFEW Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NH) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredRevolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial UnderwayTiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!Interactive Offers | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...Timothy Sykes | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NantHealth, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NantHealth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NH Stock Alerts